Authors:
Bosland, MC
Kato, I
Melamed, J
Taneja, S
Lepor, H
Torre, P
Walden, P
Zeleniuch-Jacquotte, A
Lumey, LH
Citation: Mc. Bosland et al., Chemoprevention trials in men with prostate-specific antigen failure or athigh risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein, UROLOGY, 57(4A), 2001, pp. 202-204
Authors:
Rossman, TG
Uddin, AN
Burns, FJ
Bosland, MC
Citation: Tg. Rossman et al., Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: An animal model for arsenic carcinogenesis, TOX APPL PH, 176(1), 2001, pp. 64-71
Authors:
Condon, MS
Kapan, LAE
Crivello, JF
Horton, L
Bosland, MC
Citation: Ms. Condon et al., Multiple pathways of prostate carcinogenesis analyzed by using cultured cells isolated from rats treated with N-methyl-N-nitrosourea and testosterone, MOL CARCINO, 25(3), 1999, pp. 179-186
Citation: Mc. Bosland, Use of animal models in defining efficacy of chemoprevention agents against prostate cancer, EUR UROL, 35(5-6), 1999, pp. 459-463
Authors:
Rao, KVN
Johnson, WD
Bosland, MC
Lubet, RA
Steele, VE
Kelloff, GJ
McCormick, DL
Citation: Kvn. Rao et al., Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone, CANCER RES, 59(13), 1999, pp. 3084-3089